National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Dictionary of Cancer Terms
Send to Printer
SAHA

 Suberoylanilide hydroxamic acid. A drug that is used to treat cutaneous T-cell lymphoma that does not get better, gets worse, or comes back during or after treatment with other drugs. It is also being studied in the treatment of other types of cancer. SAHA belongs to the family of drugs called histone deacetylase inhibitors. Also called suberoylanilide hydroxamic acid, vorinostat, and Zolinza.

Previous Definitions:S-phase fraction, S100 calcium binding protein A8, S100 calcium binding protein A9, sacrum, safingol
Next Definitions:saline, saliva, salivary gland, salivary gland cancer, salpingo-oophorectomy